Mesoblast
formerly Mesoblast LimitedMelbourne, Australia · Founded 2004 · $21.6M raised
- Headquarters
- Melbourne
- Employees
- 51–200
- Founded
- 2004
- Business Model
- B2B
- Website
- mesoblast.com
- Total Funding
- $21.6M
- Last Round
- $21.6M Growth EquityJan 2012
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds for this company. The full record is or through the API.
About
Mesoblast is an Australian regenerative medicine company developing cell-based therapies for inflammatory ailments and cardiovascular disease.
Summary
Mesoblast is a Biotech company based in Melbourne, Australia, founded in 2004. It has raised $21.6M in total across 1 round, most recently a $21.6M Growth Equity round in Jan 2012.
Funding & Exit History
Mar 2018
Sign up to see all 3 events
Funding: Growth Equity. Amounts, valuations, and investors where available.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/mesoblast"><img src="https://indexed.vc/api/badge/company/mesoblast" alt="Mesoblast on Indexed.vc" width="260" height="76" /></a>